Less blood expense, improved patient outcomes: Jefferson’s blood and anemia program
Tuesday, August 9th, 2022 | 11:00 AM - 12:00 PM CT
While many U.S. health systems have enforced varying efforts to reduce blood utilization and associated costs, most have yet to unlock the full clinical and economic benefits of a comprehensive Patient Blood Management (cPBM) program which includes a robust Anemia Management program.
These programs consistently yield 40 percent to 60 percent reductions in blood use, generate millions of dollars in economic benefits with bottom line cost savings, create new outpatient infusion revenue, and improve clinical outcomes such as reduced complications and hospital length of stay.
Discover how lab and clinical leadership at Jefferson Health implemented a cPBM program to transform the culture of their organization and deliver profound clinical and economic value to the organization.
Key learning objectives:
These programs consistently yield 40 percent to 60 percent reductions in blood use, generate millions of dollars in economic benefits with bottom line cost savings, create new outpatient infusion revenue, and improve clinical outcomes such as reduced complications and hospital length of stay.
Discover how lab and clinical leadership at Jefferson Health implemented a cPBM program to transform the culture of their organization and deliver profound clinical and economic value to the organization.
Key learning objectives:
- Understand the clinical and business case for executing a comprehensive blood and anemia management program
- Review the results of the Jefferson Health comprehensive Patient Blood Management case study
- Determine best practices and lessons learned throughout the implementation of the cPBM program at Jefferson Health
Presenters
Joseph Thomas, BSN, RN
Vice President, Clinical Strategic Partnerships
Accumen Inc.
joethomas@accumen.com
Chris Tomlinson, MBA
Enterprise Vice President, Clinical Lab/Pathology & Radiology/Imaging
Jefferson Health
Christopher.tomlinson@jefferson.edu